Xenon Pharmaceuticals Inc. Quarterly Return On Equity in % from Q2 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Xenon Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q2 2015 to Q3 2024.
  • Xenon Pharmaceuticals Inc. Return On Equity for the quarter ending September 30, 2024 was -24.7 %, a 5.11% increase year-over-year.
  • Xenon Pharmaceuticals Inc. annual Return On Equity for 2023 was -25.2 %, a 40.7% decline from 2022.
  • Xenon Pharmaceuticals Inc. annual Return On Equity for 2022 was -17.9 %, a 24.4% increase from 2021.
  • Xenon Pharmaceuticals Inc. annual Return On Equity for 2021 was -23.7 %, a 50% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -24.7 +1.33 +5.11% Jul 1, 2024 Sep 30, 2024
Q2 2024 -24.2 -0.83 -3.56% Apr 1, 2024 Jun 30, 2024
Q1 2024 -24.4 -4.34 -21.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -25.2 -7.28 -40.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -26 -8.75 -50.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -23.3 -6.05 -35% Apr 1, 2023 Jun 30, 2023
Q1 2023 -20 +0.72 +3.47% Jan 1, 2023 Mar 31, 2023
Q4 2022 -17.9 +5.79 +24.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -17.3 +10.3 +37.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -17.3 +9.37 +35.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -20.7 -2.6 -14.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -23.7 -7.9 -50% Oct 1, 2021 Dec 31, 2021
Q3 2021 -27.5 -10.4 -60.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -26.6 -6.11 -29.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -18.1 +16.4 +47.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -15.8 +32.9 +67.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -17.1 +26.8 +61% Jul 1, 2020 Sep 30, 2020
Q2 2020 -20.5 +25 +54.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -34.5 +12.6 +26.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -48.7 -1.7 -3.62% Oct 1, 2019 Dec 31, 2019
Q3 2019 -44 +16.2 +26.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -45.5 +23.6 +34.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 -47.1 +21 +30.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -47 +18.7 +28.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 -60.1 -6.8 -12.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -69.1 -21.6 -45.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -68.1 -23.3 -51.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -65.7 -28 -74.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -53.3 -18.6 -53.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -47.5 -18.7 -64.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -44.9 -28.9 -182% Jan 1, 2017 Mar 31, 2017
Q4 2016 -37.7 -12.7 -51.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -34.7 -18.7 -117% Jul 1, 2016 Sep 30, 2016
Q2 2016 -28.9 -36.2 -493% Apr 1, 2016 Jun 30, 2016
Q1 2016 -15.9 Jan 1, 2016 Mar 31, 2016
Q4 2015 -25 Oct 1, 2015 Dec 31, 2015
Q3 2015 -16 Jul 1, 2015 Sep 30, 2015
Q2 2015 7.34 Apr 1, 2015 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.